Figure 2: Expression of CD30 in diploid or karyotypically abnormal hES cell lines. Figure 3: Flow-cytometric analysis of CD30 expression in abnormal and diploid hES cell lines. Figure 4: Combined ...
Rituximab maintenance Therapy in B-cell lymphoma: A meta-analysis. A phase I trial of lenalidomide maintenance after autologous stem cell transplant (ASCT) in patients with high-risk ...
CD30 is a member of the tumor necrosis factor receptor superfamily. It is characteristically expressed in certain hematopoietic malignancies, including anaplastic large cell lymphoma and Hodgkin ...
Hodgkin's lymphoma and anaplastic large-cell lymphoma are the two most common tumors expressing CD30. Previous attempts to target the CD30 antigen with monoclonal-based therapies have shown minimal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results